This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2005-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005-2008
Title: Chatchai Tayapiwatana: Innovator in Recombinant DNA Technology
Introduction
Chatchai Tayapiwatana is a prominent inventor based in Bangkok, Thailand. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant DNA-derived proteins. With a total of 3 patents, his work has advanced the understanding and application of thrombolysis and protein production in prokaryotic cells.
Latest Patents
One of his latest patents is titled "Methods for large scale production of recombinant DNA-derived tPA or K2S molecules." This invention focuses on the production of tissue plasminogen activator (tPA) derivatives in prokaryotic cells. The method allows for the secretion of tPA or K2S molecules as active and correctly folded proteins. The prokaryotic cells utilized in this process express a vector that contains the DNA coding for tPA or K2S, linked to the signal peptide OmpA.
Another notable patent is "Methods for large scale protein production in prokaryotes." This invention pertains to the production of recombinant DNA-derived heterologous proteins in prokaryotic cells. Similar to his previous work, this method ensures that the heterologous protein is secreted extracellularly as an active and correctly folded protein, utilizing the same vector system.
Career Highlights
Chatchai Tayapiwatana is currently employed at Boehringer Ingelheim International GmbH, where he continues to innovate in the field of biotechnology. His expertise in recombinant DNA technology has positioned him as a key player in the development of new therapeutic proteins.
Collaborations
Throughout his career, Chatchai has collaborated with notable colleagues, including Jiradej Manosroi and Aranya Manosroi. These collaborations have further enriched his research and contributed to the advancement of their shared goals in biotechnology.
Conclusion
Chatchai Tayapiwatana's contributions to recombinant DNA technology and protein production are noteworthy. His innovative patents and ongoing work at Boehringer Ingelheim International GmbH highlight his commitment to advancing biotechnology. His efforts continue to pave the way for new therapeutic developments in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile